If you need more lookups,
subscriptions start at $34 USD/month.
Patrick Garcia Location
Geneva, GE, CH
Patrick Garcia Work
Vice President Global Brand Lead Xevinapant Global Business Franchise @ (July 2021 - Present)
Business Unit Director Oncology Germany @ (November 2018 - June 2021)
Strategic Marketing Lead Oncology, Europe @ (January 2017 - May 2019)
Director, I-O and Oncology Product and Portfolio Strategy @ (August 2014 - January 2017)
Therapeutic Area Lead Oncology Nordics @ (June 2013 - July 2014)
Associate Director Yervoy Marketing Europe @ (July 2012 - May 2013)
European Medical Communication Lead Yervoy @ (August 2008 - July 2012)
Medical Advisor Cardiovascular and Pain @ (August 2006 - August 2008)
Medical Science Manager @ (August 2005 - July 2006)
Patrick Garcia Education
University of Zurich
Doctor of Philosophy (Molecular Biology)
2002-2005
University of Basel
Master of Science (Biochemistry)
1997-2002
Patrick Garcia Skills
Clinical Trials
Medical Writing
Cardiology
Dermatology
Infectious Diseases
Clinical Research
Biotechnology
Immunology
Life Sciences
Hematology
Pharmacovigilance
Hospital Sales
Lifesciences
Sales Effectiveness
Oncology
Drug Development
Pharmaceutical Marketing
Clinical Development
Endocrinology
Diabetes
Educational Leadership
Product Launch
Immunotherapy
Pharmaceutical Industry
Market Access
Pharmaceutical Sales
Therapeutic Areas
Medical Affairs
Patrick Garcia Summary
Patrick Garcia, based in Geneva, GE, CH, is currently a Vice President Global Brand Lead Xevinapant Global Business Franchise at Merck Group. Patrick Garcia brings experience from previous roles at Merck Group and Bristol-Myers Squibb. Patrick Garcia holds a 2002 - 2005 Doctor of Philosophy in Molecular Biology @ University of Zurich. With a robust skill set that includes Clinical Trials, Medical Writing, Cardiology, Dermatology, Infectious Diseases and more. Patrick Garcia has 3 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Patrick Garcia?
Find contact details for 700 million professionals.